Medicus Sciences Acquisition Corp.
MSACNASDAQFinancial Services
$10.17
+$0.01(+0.05%)
Market Cap$0
P/E Ratio—
52W High$10.18
52W Low$9.72
Medicus Sciences Acquisition Corp. (MSAC) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · MSAC · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2021-12 |
|---|---|
| Revenue | |
| Revenue | $0.00B |
| Cost of Revenue | $0.00B |
| Gross Profit | ($0.00B) |
| Gross Margin %(computed) | — |
| Operating Expenses | |
| R&D Expenses | $0.00B |
| G&A Expenses | $0.00B |
| Total Operating Expenses | $0.00B |
| Operating Income | ($0.00B) |
| Operating Margin %(computed) | — |
| Interest Income | $0.00B |
| Interest Expense | $0.00B |
| Income Before Tax | $0.00B |
| Income Tax Expense | $0.00B |
| Net Income | $0.00B |
| Net Margin %(computed) | — |
| Per Share & EBITDA | |
| EPS (Basic) | $0.18 |
| Wtd Avg Shares | 0.01B |
| EBITDA | ($0.00B) |
| EBITDA Margin %(computed) | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · B
Explore more Medicus Sciences Acquisition Corp. data
About Medicus Sciences Acquisition Corp. (MSAC) Income Statement
Medicus Sciences Acquisition Corp. (MSAC) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2021, MSAC reported revenue of $0.00B, gross profit of ($0.00B) (gross margin —), and net income of $0.00B — a net profit margin of —.
Frequently asked questions
MSAC · 4 questionsMedicus Sciences Acquisition Corp. (MSAC) reported revenue of $0.00B for 2021, down —% year-over-year.
MSAC revenueMSAC salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09